The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
17 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,324,055 in first-year total cost, median $77,375.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRLB-2 (M2)]7
- Special Emphasis Panel[ZCA1 SRLB-J (O1)]5
- Special Emphasis Panel[ZCA1 SRLB-Y (J2)]5
Most frequent institutions
- PENNSYLVANIA STATE UNIV HERSHEY MED CTR2
- BRIGHAM AND WOMEN'S HOSPITAL1
- CASE WESTERN RESERVE UNIVERSITY1
- MASSACHUSETTS GENERAL HOSPITAL1
- MAYO CLINIC ROCHESTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Effect of magnesium treatment on vitamin D resistance1R03CA189455-01 | SHRUBSOLE, MARTHA J. | VANDERBILT UNIVERSITY, TN | $87,802 | ZCA1 |
| 2014 | Early diagnosis of colon cancer with computer-aided multi-energy CT colonography1R03CA182107-01 | NAPPI, JANNE JOHANNES | MASSACHUSETTS GENERAL HOSPITAL, MA | $87,000 | ZCA1 |
| 2014 | Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer1R03CA189462-01 | DINULESCU, DANIELA M | BRIGHAM AND WOMEN'S HOSPITAL, MA | $85,057 | ZCA1 |
| 2014 | Discovering New Targets for Chemoprevention in Familial Adenomatous Polyposis1R03CA176788-01A1 | VILAR SANCHEZ, EDUARDO | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $80,000 | ZCA1 |
| 2014 | Macrophage COX-2 as a target in breast cancer chemoprevention1R03CA171661-01A1 | CORMODE, DAVID PETER | UNIVERSITY OF PENNSYLVANIA, PA | $80,000 | ZCA1 |
| 2014 | Chemoprevention through Chromatin modulation in Barrett's esophagus1R03CA189404-01 | BUTTAR, NAVTEJ S | MAYO CLINIC ROCHESTER, MN | $79,500 | ZCA1 |
| 2014 | Prevention of Metastasis by Green Tea Polyphenols1R03CA186179-01A1 | GUPTA, SANJAY | CASE WESTERN RESERVE UNIVERSITY, OH | $79,250 | ZCA1 |
| 2014 | The addition of fish oil to sorafenib may prevent kidney cancer metastasis1R03CA181837-01 | WEISS, ROBERT H. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $77,500 | ZCA1 |
| 2014 | Development of a Silibinin/Vitamin D Regimen for Colon Cancer Prevention1R03CA176738-01A1 | FALZON, MIRIAM | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $77,375 | ZCA1 |
| 2014 | Chemoprevention of colon cancer by a novel COX-2 inhibitor1R03CA180539-01A1 | DESAI, DHIMANT HARKISAN | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $76,500 | ZCA1 |
| 2014 | Chemoprotective role of silver nanoparticles in UV radiation-induced skin carcino1R03CA186233-01 | SINGH, SEEMA | UNIVERSITY OF SOUTH ALABAMA, AL | $75,500 | ZCA1 |
| 2014 | New Aminothiol Prevention of X-Ray-Induced Mouse Mutagenesis and Tumorigenesis1R03CA176799-01A1 | FAHL, WILLIAM E | UNIVERSITY OF WISCONSIN-MADISON, WI | $75,250 | ZCA1 |
| 2014 | Evaluation of T Cell Response to Cisplatin Resistant NSCLC1R03CA172954-01A1 | YANNELLI, JOHN R. | UNIVERSITY OF KENTUCKY, KY | $75,000 | ZCA1 |
| 2014 | A novel compound for colorectal cancer prevention1R03CA181845-01A1 | SHARMA, ARUN K | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $74,521 | ZCA1 |
| 2014 | Targeting cancer stem cell initiation during pancreatic cancer development1R03CA181584-01A1 | MOHAMMED, ALTAF | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $74,000 | ZCA1 |
| 2014 | Protein Kinase D3 as a Novel Biomarker for Triple-negative Breast Cancer1R03CA181996-01A1 | TANG, HUA | UNIVERSITY OF TEXAS HLTH CTR AT TYLER, TX | $71,500 | ZCA1 |
| 2014 | Inflammation, autoimmunity and ovarian cancer1R03CA182120-01 | LUBORSKY, JUDITH L | WOODS HOLE OCEANOGRAPHIC INSTITUTION, MA | $68,300 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.